PTYLTD
    • Insights
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Insights

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic

By Topic

Suncorp Group (ASX: SUN)

Suncorp Group (ASX: SUN): Slower Growth, Steady Margins and a Bigger Bet on AI

Oct 29, 2026
Proactive Equities Team

Suncorp Group(ASX: SUN) has trimmed its premium growth outlook after losing a large commercial contract, yet its margin guidance and buyback plans are unchanged as the insurer turns its technology and AI investments into long-term earnings.

Appen (ASX: APX)

Appen (ASX: APX): Frontier AI Wins and China Surge Return Global Arm to Profit

Oct 29, 2026
Proactive Equities Team

Appen (ASX: APX) lifted September quarter revenue 34% to $73.9 million as its Global division returned to profit, two US frontier AI labs signed on, and China kept growing strongly, while full-year guidance was held steady.

Bendigo and Adelaide Bank (ASX: BEN)

Bendigo and Adelaide Bank (ASX: BEN): Cash Earnings Rebound as Risk Remediation and Softer Lending Test Investors

Oct 28, 2026
Proactive Equities Team

Bendigo and Adelaide Bank (ASX: BEN) lifted first-quarter cash earnings to $112.7 million and pays a 6% fully franked dividend, while regulatory remediation, softer lending and the RACQ Bank deal shape its outlook.

Elk Range Mining (ASX: ELK)

Elk Range Mining (ASX: ELK): Maiden Drilling Reveals High-Grade Gold at Friday Gold Project

Oct 28, 2026
Proactive Equities Team

Elk Range Mining (ASX: ELK) has reported high-grade gold results from its maiden drilling program at the Friday Gold Project in Idaho, with mineralisation extending below historical drilling limits and further assays expected in late November 2026.

Resonance Health (ASX: RHT)

Resonance Health (ASX: RHT): Preliminary Liver Fibrosis Results Open New Clinical Trial Opportunities

Oct 28, 2026
Proactive Equities Team

Resonance Health (ASX: RHT) has reported preliminary results from a liver fibrosis study and raised A$6 million to support growth, with its MRI-based assessment technology targeting new opportunities in pharmaceutical clinical trials involving GLP-1 therapies.

Monadelphous (ASX: MND)

Monadelphous (ASX: MND): $150M in New Contracts Strengthens Resources Sector Position

Oct 28, 2026
Proactive Equities Team

Monadelphous (ASX: MND) has secured about A$150 million in new resource contracts with Rio Tinto, BHP, and Whitehaven Coal, supporting ongoing project activity and strengthening its position in Australia’s resources sector.

...

 

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

1...567...88
Page 6 of 88